Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome.
Taga T, Tanaka S, Hasegawa D, Terui K, Toki T, Iwamoto S, Hiramatsu H, Miyamura T, Hashii Y, Moritake H, Nakayama H, Takahashi H, Shimada A, Taki T, Ito E, Hama A, Ito M, Koh K, Hasegawa D, Saito AM, Adachi S, Tomizawa D.
Taga T, et al. Among authors: taki t.
Leukemia. 2021 Sep;35(9):2508-2516. doi: 10.1038/s41375-021-01157-w. Epub 2021 Feb 15.
Leukemia. 2021.
PMID: 33589754